Argus
•
Oct 30, 2026
Thermo Fisher Scientific Inc.: Raising target price to $780
Summary
Thermo Fisher Scientific Inc. is a large-cap life sciences company that manufactures scientific instruments, consumables, and chemicals. The company employs 125,000 people. The shares are a component of the S&P 500.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Daily – Vickers Top Buyers & Sellers for 10/30/2026
Oct 30, 2026
•
TFC, IBKR, ENVA, HBAN, DINO, TRV, XYL, PNFP, DHR
Analyst Report: Stryker Corporation
Oct 30, 2026
•
SYK
Analyst Report: Linde plc
Oct 29, 2026
•
LIN
Analyst Report: Illumina, Inc.
Oct 29, 2026
•
ILMN
Technical Assessment: Bullish in the Intermediate-Term
Oct 29, 2026
•
ILMN, MS
Analyst Profile
David H. Toung
Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.
